Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,989 | 19,439 | 14,203 | 14,038 | 16,580 |
| Marketable Securities | 12,886 | N/A | N/A | N/A | N/A |
| TOTAL | $19,184 | $19,828 | $14,683 | $16,544 | $18,692 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 4 | 8 | 66 | 232 | 1,390 |
| TOTAL | $4 | $8 | $66 | $232 | $1,390 |
| Total Assets | $19,188 | $19,836 | $14,749 | $16,776 | $20,082 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 441 | 589 | 562 | 770 | 2,714 |
| Other current liabilities | N/A | N/A | N/A | N/A | 56 |
| TOTAL | $441 | $589 | $562 | $770 | $2,770 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $441 | $589 | $562 | $770 | $2,770 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,516 | 14,255 | 13,410 | 13,410 | 13,380 |
| Common Shares | 1,343 | 1,342 | 1,334 | 1,334 | 1,334 |
| Retained earnings | -548,817 | -547,636 | -546,092 | -543,637 | -540,609 |
| TOTAL | $18,747 | $19,247 | $14,187 | $16,006 | $17,312 |
| Total Liabilities And Equity | $19,188 | $19,836 | $14,749 | $16,776 | $20,082 |